|
|
|
|
|
|
|
|
Faculty
|
 |
|
Faculty members with appointments in the Department of Microbiology and Immunology are listed by campus with a brief description of their professional interests. For more detailed information about individual faculty members, click on their respective links.
Queen Lane Campus
| Carol Artlett |
Role of 3-deoxyglucosone in mediating inflammation in diabetes and autoimmunity and the role of allograft inflammatory factor-1 in systemic sclerosis
|
|
Lawrence W. Bergman
|
Malarial invasion mechanisms and cellular gene expression patterns during infection |
| Elizabeth Blankenhorn |
Genetic foundations for inherited susceptibility to autoimmune diseases, including diabetes and multiple sclerosis |
| Alina Boesteanu |
Migration of dendritic cells to the lung after influenza virus infection, and the role of costimulatory molecules in the primary, secondary and memory immune responses to influenza virus |
| James Burns |
Development of protective immunity against blood-stage malaria induced by immunization with defined subunit vaccines |
| Thomas Edlind |
Molecular mechanisms of antifungal action, resistance, and toxicity |
| Santosh Katiyar |
Molecular mechanisms of antifungal resistance |
| Peter Katsikis |
Roles of cytokines, T cells, and apoptosis in autoimmunity and anti-viral immune responses |
| Kirsten Larson |
Course director of medical immunology and medical genetics, and development and implementation of both team-taught courses in our medical school curricula |
| Yvonne Mueller |
Function of virus-specific cytotoxic CD8+ T cells |
| Richard Rest |
Molecular and cellular mechanisms of the pathogenesis of Neisseria gonorrhoeae, Neisseria meningitidis, and Bacillus anthracis |
| Donna Russo |
Director of the medical school curriculum, Interdisciplinary Foundations of Medicine, as well as department course director for Medical Microbiology |
| Daniel Simon |
Bacillus anthracis and regulation of its virulence genes |
| Akhil Vaidya |
Understanding basic molecular functioning of malaria parasites with a view to develop new antimalarial drugs |
Center City Campus
|
Pooja Jain
|
Dendritic cells in autoimmune and neuroinflammatory disease |
| Stephen Jennings |
Optimal protection from HSV-1 infection provided by interactions between innate and acquired immune responses |
| Zafar K. Khan |
Human T cell leukemia virus type 1 (HTLV-1), oncoprotein Tax, Animal model of HTLV-1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP), Neuroinflammation, Demyelination, HIV-1, Microbicides
|
| Evelyn Kilareski |
HIV-1 transcriptional regulation and neuropathogenesis |
| Fred Krebs |
HIV-1 immunopathogensis and neuropathogenesis, development of microbicidal agents |
|
Julio Martín-García
|
HIV-1 envelope-mediated fusion and entry, HIV neurotropism and neuropathogenesis
|
| Sonia Navas-Martín |
Molecular pathogenesis and evolution of RNA viruses. Animal models for viral infectious diseases. |
| Michael Nonnemacher |
Impact of genetic variation and drugs of abuse on HIV-1 and SIV replication and pathogenesis |
|
Laura Steel
|
Development of RNAi-based therapies for hepatitis B virus (HBV) |
| Brian Wigdahl |
Immunopathogenesis and neuropathogenesis of HIV-1 and HTLV-I infection, transcriptional regulation of retroviral expression, viral sequence diversity and correlations to disease, development of microbicidal agents
|
Doylestown Campus
Drexel Institute for Biotechnology and Virology Research
|
Tim Block
|
Molecular mechanisms of viral persistence and development of therapeutic strategies for hepatitis B virus (HBV) and herpes simplex virus (HSV) |
| Haituo Guo |
Molecular pathway of HBV cccDNA formation and cccDNA regulation by viral and cellular factors; Development of in vitro assay systems for discovery of novel antiviral drugs. |
|
Xuanyong Lu
|
Cellular susceptibility to hepatitis B (HBV) infection; developing strategies to control cancer cell growth through silencing of overexpressed apoptosis inhibitors |
| Anand Mehta |
Development of new hepatitis B (HBV) therapeutics; identification of early markers of liver cancer |
|
Pamela Norton
|
Development of novel antiviral drugs for use against hepatitis B virus (HBV) infection; host cell defenses against HBV infection |
|
Ying-Hsiu Su
|
Understanding interactions between herpes simplex virus type 1 (HSV-1) and neurons during viral latency and reactivation; using nucleic acids in urine as diagnostic markers of cancer |
Allegheny General Hospital
Allegheny-Singer Research Institute
Center for Genomic Sciences
Pittsburgh, PA
|
James Christopher Post
|
Role of biofilms in chronic human infections using otitis media as a model. Genetics of human performance, scarless wound healing. |
|
Paul Stoodley
|
Growth and control of bacterial biofilms in nature, industry, and medicine |
Secondary Faculty
|
Kenneth Blank
|
Analysis of the genetic regulation of host-virus interactions that occur
during infection with retrovirus |
| Michael Bouchard |
Molecular mechanisms through which HBx influences cellular signaling
cascades and the consequences of this for HBV replication and the
development of liver cancer |
| Jeffery Jacobson |
Immune cell-based vaccines as therapies for HIV infection and novel
inhibitors of cell entry against HIV
|
| Michelle Kutzler |
Develop next generation optimized DNA vaccine based strategies that target
antigen-specific cellular and humoral immune responses to mucosal sites |
| Edward Schulman |
|
|
|
|
|
|
|
|
| Copyright (c) 2008 Drexel University College of Medicine
|
|
Philadelphia Health & Education Corporation d/b/a Drexel University College of Medicine is a separate not-for-profit subsidiary of Drexel University.
|
|